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Advances in automated imaging microscopy allow fast
acquisitions of multidimensional biological samples.
Those microscopes open new possibilities for analyzing
subcellular structures and spatial cellular arrangements.
We present a 3D image analysis framework perfectly
well suited for medium-throughput screening. Upon
adaptive and regularized segmentation, followed by pre-
cise 3D reconstruction, we achieve automatic quantifica-
tion of numerous relevant 3D descriptors related to the
shape, texture, and fluorescence intensity of multiple
stained subcellular structures. A global analysis of the
3D reconstructed scene shows additional possibilities to
quantify the relative position of organelles. Implement-
ing this methodology, we analyzed the subcellular reor-
ganization of the nucleus, the Golgi apparatus and the
centrioles occurring during the cell cycle. In addition,
we quantified the effect of a genetic mutation associated
with the early onset primary dystonia on the redistribu-
tion of torsinA from the bulk endoplasmic reticulum to
the perinuclear space of the nuclear envelope. We show
that the method enables the classification of various
translocation levels of torsinA and opens the possibility
for compound-based screening campaigns. Finally we
present real applications of 3D cellular phenotype quan-
tification in the screening context.
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